FDA pushes forward on gene-editing therapies with new safety roadmap
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
At the core of Verida is Spectral Precise Image technology paired with a third-generation Nano-panel Precise dual-layer detector and an AI-based deep learning reconstruction engine
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Subscribe To Our Newsletter & Stay Updated